top of page

HD-tDCS as augmentation therapy in late-life depression

Departmental Research Seminar

Presented by: 

Dr. Calvin Pak Wing CHENG

Chaired by:

Dr. Calvin Pak Wing CHENG


23 April 2020


6:30 am


7:05 am


To be held by Zoom


HD-tDCS has great potential as a new treatment option for depression based on its effects on neural plasticity and enhancement of serotonin and cognitive function. A previous meta-analysis suggested the effectiveness and tolerability in patients with depression, despite the conflicting results. The efficacy of HD-tDCS in patients with LLD remains unknown due to the scarcity of research.

Please send the following information to by 16 April, 2020 (Thursday) for registration.
1. Full name;
2. Email address

Add Photo(s)
bottom of page